Clinical Trial Update: Low and Conventional Dose of Somatropin in Growth Hormone Deficient Adult Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating low and conventional doses of somatropin in adults with growth hormone deficiency; study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Drugs mentioned

• HUMATROPE (somatropin)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Growth Hormone Deficiency | Phase 3 | Status: COMPLETED